logo-loader

Tissue Regenix Group PLC

Receive alerts
Market:
AIM
Market Cap:
£12.13 m
Price
1.04 GBX
Change
-5.90%
52 weeks high
8.40
52 weeks low
0.45

In brief

TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.

We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.

Deep dive We explore the investor case for growth companies

Snapshot

The company has two products spanning wound care, orthopaedics and cardiac applications which are based on two proven technologies